Patients with palmoplantar psoriasis have more physical disability and discomfort than patients with other forms of psoriasis: Implications for clinical practice

被引:120
作者
Pettey, AA
Balkrishnan, R
Rapp, SR
Fleischer, AB
Feldman, SR
机构
[1] Wake Forest Univ, Sch Med, Dept Dermatol, Winston Salem, NC 27104 USA
[2] Wake Forest Univ, Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27104 USA
[3] Wake Forest Univ, Sch Med, Dept Psychiat, Winston Salem, NC 27104 USA
关键词
D O I
10.1067/S0190-9622(03)01479-8
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Psoriasis is a chronic, unpredictable, and incurable disease that has a negative impact on patients quality of life. Palm and sole psoriasis can add to this negative impact as it directly affects activities of daily living. Objective: We Sought to estimate the prevalence of palmoplantar psoriasis in a patient population bind to explore associations with patient Outcomes. Methods: In all, 317 individuals with psoriasis completed a comprehensive assessment battery. Patients with palmoplantar psoriasis (n = 124, 39%) were compared with patients without palmoplantar involvement with respect to functional disability, psychiatric symptoms, physical and social discomfort, self-reported psoriasis severity, and health-related quality of life. Results: Patients with palmoplantar involvement reported significantly greater physical disability and physical discomfort than patients without palmoplantar involvement (both P < .01). There were no differences between the 2 groups with respect to psychosocial outcomes. Conclusion. Patients with palmoplantar psoriasis are affected to a greater degree by the physical aspects of the disease than patients Without palmoplantar involvement.
引用
收藏
页码:271 / 275
页数:5
相关论文
共 19 条
[1]  
[Anonymous], PSORIASIS
[2]  
Derogatis L.R., 1982, BRIEF SYMPTOM INVENT
[3]  
FARBER EM, 1992, CUTIS, V50, P407
[4]   The economic impact of psoriasis increases with psoriasis severity [J].
Feldman, SR ;
Fleischer, AB ;
Reboussin, DM ;
Rapp, SR ;
Bradham, DD ;
Exum, ML ;
Clark, AR .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 37 (04) :564-569
[5]   The self-administered psoriasis area and severity index is valid and reliable [J].
Feldman, SR ;
Fleischer, AB ;
Reboussin, DM ;
Rapp, SR ;
Exum, ML ;
Clark, AR ;
Nurre, L .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (01) :183-186
[6]   DERMATOLOGY LIFE QUALITY INDEX (DLQI) - A SIMPLE PRACTICAL MEASURE FOR ROUTINE CLINICAL USE [J].
FINLAY, AY ;
KHAN, GK .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1994, 19 (03) :210-216
[7]  
FINLAY AY, 1995, BRIT J DERMATOL, V132, P236
[8]  
Fleischer AB, 1996, CUTIS, V58, P216
[9]   PATIENT MEASUREMENT OF PSORIASIS DISEASE SEVERITY WITH A STRUCTURED INSTRUMENT [J].
FLEISCHER, AB ;
RAPP, SR ;
REBOUSSIN, DM ;
VANARTHOS, JC ;
FELDMAN, SR .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (06) :967-969
[10]   Disease severity measures in a population of psoriasis patients: The symptoms of psoriasis correlate with self-administered psoriasis area severity index scores [J].
Fleischer, AB ;
Feldman, SR ;
Rapp, SR ;
Reboussin, DM ;
Clark, AR ;
Rajashekhar, V .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 107 (01) :26-29